BIT 7.50% 3.7¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-111

  1. 610 Posts.
    lightbulb Created with Sketch. 109
    @J8

    One of the few "novel' comments here in months.

    I think you're right re Mr Matket being underwhelmed. Not covinced its right, I suspect reaction is largely due the delays, but hard to argue regardless atm.

    Thinking you are correct re minor side affects being problematic. I note 1 withdrawal was unrelated to medication though, also they coated pill post Ph2a?

    Why dont you nelieve BP wont look straight past that cocern, maybe aim for a long acting slow release or injectable like the GILD release last week? 225 is demonstrably outperforming otherwise. Presumably its a saturation discussion and they coild say run 100 post x weeks.


    Last edited by Pseudoname1: 23/06/24
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
-0.003(7.50%)
Mkt cap ! $33.38M
Open High Low Value Volume
3.8¢ 4.0¢ 3.7¢ $13.74K 361.7K

Buyers (Bids)

No. Vol. Price($)
1 421052 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 19000 1
View Market Depth
Last trade - 15.39pm 05/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.